Hematologic effects of flt3 ligand in vivo in mice

scientific article published on 01 September 1996

Hematologic effects of flt3 ligand in vivo in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8822919

P50authorDouglas E. WilliamsQ111326907
Stewart D. LymanQ111337179
Hilary J. McKennaQ111337352
P2093author name stringLee CC
Morris AE
Morrissey PJ
Brasel K
Charrier K
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)2004-2012
P577publication date1996-09-01
P1433published inBloodQ885070
P1476titleHematologic effects of flt3 ligand in vivo in mice
P478volume88

Reverse relations

cites work (P2860)
Q36983731A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration
Q58096557AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34 Progenitor Cell Engraftment in Humanized Mice
Q36026031Allergic airway inflammation
Q34602386Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly related to precursor number.
Q33907236Attenuation of vaccinia virus by the expression of human Flt3 ligand
Q33749336Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: potential involvement of very small embryonic-like cells.
Q36319530CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1.
Q37234292CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation
Q34089167Classical Flt3L-dependent dendritic cells control immunity to protein vaccine
Q33887809Control of B cell development by Ras-mediated activation of Raf.
Q36607055Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors
Q90069593Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche
Q37590337Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines
Q39278063Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae
Q41832921Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity
Q36367631Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified
Q28583154Effect of Flt3 ligand gene transfer in experimental pancreatic cancer
Q34626662Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis
Q43289248Expression, purification and characterization of the extracellular domain of human Flt3 ligand in Escherichia coli
Q38759255FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche
Q37619537FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.
Q38497229Fate mapping of dendritic cells
Q34973744Flt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes
Q36371293Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo
Q58778314Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses
Q42739962Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration
Q34541467Immune therapy for breast cancer in 2010-hype or hope?
Q33856002Immunotherapeutic approaches for the treatment of breast cancer
Q42326966Improved bicistronic mammalian expression vectors using expression augmenting sequence element (EASE).
Q36618076In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques
Q34076517In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis
Q36943742Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes
Q38035032Innate immunity and the regulation and mobilization of keratinocyte stem cells: are the old players playing a new game?
Q34309830Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.
Q39917950Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line
Q34453798LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling
Q36745048Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses
Q36275693Maturation of function in dendritic cells for tolerance and immunity.
Q89558892Mobilized peripheral blood: an updated perspective
Q73196801Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties
Q36369285Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response
Q24607533Novel vaccine development strategies for inducing mucosal immunity
Q28592017Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6
Q73147768Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant
Q33811836Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment
Q48219588Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.
Q35604052Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis
Q24598872RANK is essential for osteoclast and lymph node development
Q34607733RNA sequencing and transcriptomal analysis of human monocyte to macrophage differentiation
Q45737807Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells
Q42229089Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment.
Q39607848Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Q25256900Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
Q48197487Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis
Q46705750Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse
Q35011710Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice
Q34910186Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus
Q46821465The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse
Q64917514The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.
Q28510383The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues
Q78157743Visualizing the T-cell response elicited by oral administration of soluble protein antigen

Search more.